Novel dopamine therapeutics for cognitive deficits in schizophrenia

AFT Arnsten, RR Girgis, DL Gray, RB Mailman - Biological psychiatry, 2017 - Elsevier
Schizophrenia is characterized by profound cognitive deficits that are not alleviated by
currently available medications. Many of these cognitive deficits involve dysfunction of the …

Strategies for the treatment of Parkinson's disease: beyond dopamine

A Iarkov, GE Barreto, JA Grizzell… - Frontiers in aging …, 2020 - frontiersin.org
Parkinson's disease (PD) is the second-leading cause of dementia and is characterized by a
progressive loss of dopaminergic neurons in the substantia nigra alongside the presence of …

Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs

R Franco, G Navarro - Frontiers in Pharmacology, 2023 - frontiersin.org
G protein-coupled receptors (GPCRs) are the target of hundreds of approved drugs.
Although these drugs were designed to target individual receptors, it is becoming …

The leptin, dopamine and serotonin receptors in hypothalamic POMC-neurons of normal and obese rodents

IV Romanova, KV Derkach, AL Mikhrina… - Neurochemical …, 2018 - Springer
Abstract The pro-opiomelanocortin (POMC)-expressing neurons of the hypothalamic arcuate
nucleus (ARC) are involved in the control of food intake and metabolic processes. It is …

Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor

JL Conroy, RB Free, DR Sibley - ACS chemical neuroscience, 2015 - ACS Publications
The D1 dopamine receptor (D1R) has been implicated in numerous neuropsychiatric
disorders, and D1R-selective ligands have potential as therapeutic agents. Previous studies …

[HTML][HTML] Dopamine D1-D2 receptor heteromer expression in key brain regions of rat and higher species: Upregulation in rat striatum after cocaine administration

A Hasbi, M Sivasubramanian, M Milenkovic… - Neurobiology of …, 2020 - Elsevier
Background Dopamine receptors interact with other receptors to form heterooligomers. One
such complex, the D1-D2 heteromer, demonstrated in cultured striatal neurons and rat …

Rapid anti-depressant and anxiolytic actions following dopamine D1–D2 receptor heteromer inactivation

MYF Shen, ML Perreault, FR Bambico… - European …, 2015 - Elsevier
A role for the mesolimbic dopaminergic system in the pathophysiology of depression has
become increasingly evident. Specifically, brain-derived neurotrophic factor (BDNF) has …

Chronic hypothalamic-pituitary-adrenal axis disruption alters glutamate homeostasis and neural responses to stress in male C57Bl6/N mice

SA Kinlein, NK Wallace, MI Savenkova… - Neurobiology of …, 2022 - Elsevier
It is now well-established that stress elicits brain-and body-wide changes in physiology and
has significant impacts on many aspects of health. The hypothalamic-pituitary-adrenal (HPA) …

Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons

R Rivas-Santisteban, A Muñoz, J Lillo, I Raïch… - npj Parkinson's …, 2024 - nature.com
Abstract Calcium ion (Ca2+) homeostasis is crucial for neuron function and
neurotransmission. This study focused on the actions mediated by the CB1 receptor (CB1R) …

The old and new visions of biased agonism through the prism of adenosine receptor signaling and receptor/receptor and receptor/protein interactions

R Franco, R Rivas‐Santisteban… - Frontiers in …, 2021 - frontiersin.org
Biased signaling is a concept that has arisen in the G protein-coupled receptor (GCPR)
research field, and holds promise for the development of new drug development strategies …